-+ 0.00%
-+ 0.00%
-+ 0.00%

AMPLIA ENTERS INTO SECOND AGREEMENT WITH KOREAN SPECIALIST DRUG SCREENING COMPANY NEXT&BIO TO EXPLORE COMBINATION THERAPY WITH FAK INHIBITOR AND KRAS INHIBITORS

路透·12/19/2025 13:45:00

登录查看新闻详情